Search research articles
Contact Us
Filters
Showing results (61-70 of 75) with videos related to
Page
of 8
Sort By:
European Radiology
|
April 16, 2025
User requirements for quantitative radiological reports in multiple sclerosis
David R van Nederpelt, Zoe C Mendelsohn, Lonneke Bos, et al.
ERJ Open Research
|
March 11, 2026
Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis
Munyaradzi Musvosvi, Elisa Nemes, Michele Tameris, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Performance of Human and Computer-aided Evaluation of Digital Chest Radiography for Community-based Screening of Asymptomatic Tuberculosis
Sarah Nyangu, Humphrey Mulenga, Simon C Mendelsohn, et al.
Ebiomedicine
|
March 18, 2025
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting
Michele Tameris, Virginie Rozot, Claire Imbratta, et al.
The Lancet. Global Health
|
April 18, 2025
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial
Angelique Kany Kany Luabeya, Virginie Rozot, Claire Imbratta, et al.
The Journal of Infectious Diseases
|
April 9, 2020
Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls
Sara Suliman, Anele Gela, Simon C Mendelsohn, et al.
The Lancet. Infectious Diseases
|
January 28, 2021
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
Thomas J Scriba, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
The Lancet. Global Health
|
April 16, 2021
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
Simon C Mendelsohn, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
Scientific Reports
|
May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Adam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
Cell Reports
|
April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
Pramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 75) with videos related to
Sort By:
Page
of 8
European Radiology
|
April 16, 2025
User requirements for quantitative radiological reports in multiple sclerosis
David R van Nederpelt, Zoe C Mendelsohn, Lonneke Bos, et al.
ERJ Open Research
|
March 11, 2026
Optimisation and application of a T-cell antigen-specific activation assay as diagnostic and treatment-monitoring tool for tuberculosis
Munyaradzi Musvosvi, Elisa Nemes, Michele Tameris, et al.
Medrxiv : the Preprint Server for Health Sciences
|
May 7, 2026
Performance of Human and Computer-aided Evaluation of Digital Chest Radiography for Community-based Screening of Asymptomatic Tuberculosis
Sarah Nyangu, Humphrey Mulenga, Simon C Mendelsohn, et al.
Ebiomedicine
|
March 18, 2025
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting
Michele Tameris, Virginie Rozot, Claire Imbratta, et al.
The Lancet. Global Health
|
April 18, 2025
Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b-2a, double-blind, dose-escalation, randomised controlled trial
Angelique Kany Kany Luabeya, Virginie Rozot, Claire Imbratta, et al.
The Journal of Infectious Diseases
|
April 9, 2020
Peripheral Blood Mucosal-Associated Invariant T Cells in Tuberculosis Patients and Healthy Mycobacterium tuberculosis-Exposed Controls
Sara Suliman, Anele Gela, Simon C Mendelsohn, et al.
The Lancet. Infectious Diseases
|
January 28, 2021
Biomarker-guided tuberculosis preventive therapy (CORTIS): a randomised controlled trial
Thomas J Scriba, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
The Lancet. Global Health
|
April 16, 2021
Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study
Simon C Mendelsohn, Andrew Fiore-Gartland, Adam Penn-Nicholson, et al.
Scientific Reports
|
May 27, 2020
RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response
Adam Penn-Nicholson, Stanley Kimbung Mbandi, Ethan Thompson, et al.
Cell Reports
|
April 4, 2019
Therapeutic Monoclonal Antibodies for Ebola Virus Infection Derived from Vaccinated Humans
Pramila Rijal, Sean C Elias, Samara Rosendo Machado, et al.
Page
of 8